Overexpression induces activation of the MAPK14/p38 cascade and apoptosis.
KEGG: bta:529327
UniGene: Bt.31735
Bovine RELL2 (RELT-like protein 2) is a member of the RELT family of proteins (RELTfms), which includes RELT (Receptor Expressed in Lymphoid Tissues, a Tumor Necrosis Factor Superfamily member) and RELL1. RELL2 is a Type I transmembrane protein that shares significant homology with RELT and RELL1, particularly in the transmembrane and intracellular domains.
The three proteins collectively termed RELTfms have gained research interest due to their association with various biological processes including cytokine signaling and pathways that either promote cell death or survival. Unlike RELT, which contains extracellular Cys-rich domains characteristic of TNFRSF members, RELL2 has a shorter extracellular domain (ECD) without these Cys-rich domains .
RELL2 mRNA expression in bovine tissues follows a tissue-restricted pattern similar to that observed in other species. It is predominantly expressed in:
Hematopoietic tissues (thymus, spleen)
Immune-privileged sites (testes, brain, placenta)
Peripheral blood leukocytes (PBLs)
According to gene expression data from the ARCHS4 platform, RELL2 expression is highest in cell lines of the hematopoietic system, whereas minimal RELL2 expression is found in certain tissues such as skeletal muscle . The tissue specificity of RELL2 expression suggests it may play specialized roles in immune function and development in cattle.
Bovine RELL2 encodes a 303 amino acid-long protein with a predicted molecular weight of approximately 32.4 kDa. Its structure includes:
A short extracellular domain (ECD) compared to other TNFRSF members
No extracellular Cys-rich domains (which are typically used to bind TNFSF ligands)
A single transmembrane domain
A cytoplasmic region with predicted disordered sequences in its carboxy-terminal tail
The disordered sequences in the carboxy-terminus suggest that this region may adopt multiple conformations depending on post-translational modifications or protein binding partners. This structural flexibility is a common feature among all RELTfms and likely contributes to their functional versatility .
Bovine RELL2, like its human counterpart, can interact with other RELT family proteins as demonstrated through co-immunoprecipitation (co-IP) experiments. Key aspects of these interactions include:
All RELTfms (RELT, RELL1, and RELL2) can bind to each other
Co-expression of recombinant RELTfms results in co-localization at the plasma membrane
While RELT alone tends to localize predominantly in cytosolic compartments, co-expression with either RELL1 or RELL2 enhances its localization to the plasma membrane
These protein-protein interactions suggest that RELL2 may modulate the signaling capabilities of other RELT family members, potentially creating functional diversity through heteromeric complex formation .
Based on established protocols for similar proteins, recombinant Bovine RELL2 can be produced using several expression systems:
Bacterial Expression System:
Advantages: High yield, cost-effective, relatively simple process
Challenges: Lack of post-translational modifications, potential protein misfolding
Implementation: The coding sequence for Bovine RELL2 can be cloned into vectors such as pET or pGEX systems for expression in E. coli strains like BL21(DE3)
Mammalian Expression System:
Advantages: Proper protein folding and post-translational modifications
Challenges: Lower yield, higher cost, longer production time
Implementation: Expression in HEK293 or CHO cells using vectors like pcDNA3.1
Insect Cell Expression System:
Advantages: Higher yield than mammalian cells with better post-translational modifications than bacteria
Implementation: Baculovirus expression systems in Sf9 or S2 cells, similar to methods used for other recombinant bovine proteins
| Expression System | Yield Potential | Post-translational Modifications | Complexity | Cost |
|---|---|---|---|---|
| E. coli | High | Minimal | Low | Low |
| Mammalian Cells | Low-Medium | Complete | High | High |
| Insect Cells | Medium-High | Partial | Medium | Medium |
For optimal expression of soluble recombinant Bovine RELL2, researchers should consider the following experimental design parameters:
For Bacterial Expression:
Induction conditions: Using experimental design approaches similar to those employed for other recombinant proteins, optimal parameters include:
IPTG concentration: 0.1-1.0 mM
Induction temperature: 16-25°C (lower temperatures often improve solubility)
Induction time: 4-16 hours
OD600 at induction: 0.6-0.8
Solubility enhancement strategies:
Fusion tags: GST, MBP, or SUMO tags can enhance solubility
Co-expression with chaperones: GroEL/GroES, DnaK/DnaJ/GrpE
Solubility-enhancing additives: 5-10% glycerol, 50-300 mM NaCl, 0.1-1% Triton X-100
The design of experiment (DoE) methodology, as applied for other recombinant proteins, can be used to optimize these conditions systematically rather than using a trial-and-error approach .
Verifying the functional activity of recombinant Bovine RELL2 involves multiple complementary approaches:
Structural verification:
Circular Dichroism (CD) spectroscopy to confirm proper secondary structure
Size Exclusion Chromatography (SEC) to verify oligomeric state
Western blotting using antibodies against RELL2 or epitope tags
Functional assays:
Protein-protein interaction studies:
Co-immunoprecipitation (co-IP) with other RELT family members
Surface Plasmon Resonance (SPR) to measure binding kinetics with potential partners
Proximity ligation assays in bovine cell lines
Signaling pathway analysis:
Monitoring NF-κB pathway activation using reporter assays
Phosphorylation studies of downstream effectors
Analysis of cellular responses (apoptosis, proliferation) in transfected bovine cells
Localization studies:
Based on its expression pattern predominantly in hematopoietic tissues, RELL2 likely plays significant roles in bovine immune regulation:
B lymphocyte function:
RELL2 may influence B cell maturation processes similar to how other RBPs regulate germinal center (GC) B-cell responses
It could be involved in class-switching recombination (CSR) and somatic hypermutation
Potential roles in regulating cellular proliferation and survival, similar to TIA1 and TIAL1 proteins that sustain long-term GC responses
T cell regulation:
Immunosuppressive mechanisms:
Investigation of RELL2 expression during bovine immune challenges, particularly viral or bacterial infections, would provide valuable insights into its specific immunoregulatory functions.
Advanced transcriptomic approaches for studying Bovine RELL2 expression include:
High-throughput real-time PCR:
This approach has been successfully used to monitor expression profiles of genes in bovine somatic cells under different conditions, such as rbST treatment. A similar methodology could be applied to study RELL2 expression:
Multiple timepoints sampling to capture temporal expression changes
Analysis of expression across diverse bovine tissues and cell types
Statistical analysis using both univariate and multivariate methods to identify significant changes in expression patterns
RNA-Seq analysis:
Whole transcriptome sequencing to examine RELL2 expression in relation to other genes
Identification of alternative splicing events affecting RELL2
Differential expression analysis across conditions (disease, development, treatment)
Single-cell RNA sequencing:
Cell type-specific expression patterns in heterogeneous tissue samples
Identification of specific immune cell populations expressing RELL2
Developmental trajectories of RELL2 expression
Alternative splicing analysis:
Given the importance of alternative splicing in immune regulation, analysis of RELL2 splicing variants should be considered using:
PCR with isoform-specific primers
Long-read sequencing technologies (PacBio, Nanopore)
Computational prediction of functional differences between isoforms
Post-translational modifications (PTMs) likely play crucial roles in regulating Bovine RELL2 function and stability:
Predicted PTMs for RELL2:
Phosphorylation:
The disordered carboxy-terminal region likely contains multiple phosphorylation sites
Phosphorylation may regulate protein-protein interactions and signaling capabilities
Key kinases potentially involved: MAPK, PKC, CK2
Glycosylation:
N-linked glycosylation sites may be present in the extracellular domain
Glycosylation could affect protein stability and trafficking to the plasma membrane
Analysis of recombinant protein should include glycosidase treatments to assess glycan content
Ubiquitination:
May regulate protein turnover and abundance
Could affect signaling capacity and half-life
Experimental approaches to study PTMs:
Mass spectrometry-based proteomics for comprehensive PTM mapping
Site-directed mutagenesis of predicted modification sites
Pharmacological inhibition of specific modification pathways
Comparison of PTM patterns between recombinant and native Bovine RELL2
The observed migration of recombinant RELL proteins at positions larger than predicted molecular weights, with multiple bands apparent, suggests significant post-translational modifications .
Studying RELL2 protein-protein interactions in bovine cells presents several methodological challenges:
Technical challenges:
Antibody availability:
Limited availability of bovine-specific antibodies against RELL2
Cross-reactivity issues when using antibodies developed for human RELL2
Solution: Production of custom antibodies or use of epitope-tagged recombinant proteins
Low endogenous expression:
Natural expression levels may be insufficient for certain detection methods
Tissue-specific expression patterns may necessitate working with specialized cell types
Solution: Development of sensitive detection methods or controlled overexpression systems
Membrane protein complexes:
Membrane proteins like RELL2 require special solubilization conditions
Detergent selection can affect protein-protein interactions
Solution: Optimization of membrane protein extraction protocols with mild detergents
Methodological approaches:
Proximity-based methods:
Advanced co-IP strategies:
Crosslinking prior to lysis to stabilize transient interactions
Tandem affinity purification for higher purity
Mass spectrometry identification of co-precipitated proteins
Interactome analysis:
Based on RELL2's expression pattern and its family relationship to RELT, several potential roles in livestock disease processes can be hypothesized:
Infectious diseases:
Bovine Leukemia Virus (BLV) infection:
Given RELL2's expression in hematopoietic tissues, it may influence BLV infectivity or host response
BLV causes enzootic bovine leukosis with high prevalence (30-90%) in dairy cattle worldwide
RELL2 could be investigated in the context of persistent lymphocytosis characterized by polyclonal expansion of CD5+ B-cells
Mycobacterial infections:
Oncological conditions:
Potential involvement in bovine lymphosarcoma development
Possible roles in regulating apoptosis, similar to how Nrf2 up-regulates anti-apoptotic protein Bcl-2
Expression changes in neoplastic versus healthy tissues could provide insights
Immune dysregulation:
RELL2 may influence inflammatory responses in bovine tissues
Potential involvement in cytokine signaling networks
Roles in balancing pro-inflammatory and immunosuppressive mechanisms
Research investigating RELL2 expression during these disease processes, particularly using transcriptomic approaches comparing healthy and affected tissues, would provide valuable insights into its pathophysiological relevance.
CRISPR/Cas9 technology offers powerful approaches to investigate Bovine RELL2 function:
Genome editing strategies:
Gene knockout:
Complete RELL2 deletion to assess loss-of-function phenotypes
Target guide RNA design to early exons for maximum disruption
Verification through sequencing, RT-PCR, and Western blotting
Domain-specific mutations:
Precise editing of key domains (transmembrane, cytoplasmic regions)
Introduction of point mutations to disrupt specific protein-protein interactions
Creation of truncation mutants to study domain functions
Regulatory element editing:
Modification of RELL2 promoter regions to study expression regulation
Targeting potential enhancer elements identified through epigenomic profiling
Analysis of transcription factor binding sites involvement
Experimental approaches:
In vitro cellular models:
Editing in bovine cell lines (e.g., MDBK cells, BL3.1 B lymphocyte line)
Phenotypic analysis of edited cells (proliferation, apoptosis, cytokine responses)
Transcriptomic and proteomic profiling of knockout vs. wild-type cells
CRISPR activation/inhibition:
CRISPRa (dCas9-activator) to upregulate RELL2 expression
CRISPRi (dCas9-repressor) to downregulate expression without genomic changes
Temporal control using inducible systems
CRISPR screening:
Genome-wide screens to identify genetic interactors of RELL2
Focused screens targeting immune pathways
Analysis of synthetic lethal/viable interactions
This approach has been successfully applied in studying immune factors in bovine cells, revealing that critical immune factors including IFNAR2 and IL2RB are transcriptionally regulated by specific enhancer elements .
Structural predictions suggest several potential roles for Bovine RELL2 in signaling pathways:
Predicted signaling activities:
NF-κB pathway interactions:
MAPK signaling:
Cytokine signaling modulation:
Structural determinants of signaling:
The disordered C-terminal region likely contains multiple protein-protein interaction motifs
The transmembrane domain may participate in receptor clustering
Co-localization with other RELTfms at the plasma membrane suggests potential for heteromeric signaling complexes
Research using phosphoproteomic analysis following RELL2 activation or inhibition would help elucidate its specific signaling roles and targets in bovine cells.
Alternative splicing (AS) likely plays a significant role in regulating RELL2 expression and function in bovine tissues:
Predicted splicing regulation:
Tissue-specific isoforms:
Different bovine tissues may express distinct RELL2 isoforms with specialized functions
Hematopoietic versus non-hematopoietic tissues might utilize different splicing patterns
Developmental stages may feature transitions between isoforms
Regulatory mechanisms:
Functional consequences:
Isoforms may differ in cellular localization (membrane vs. cytoplasmic)
Alternative C-termini could alter protein interaction capabilities
Variations in the extracellular domain might affect ligand binding properties
Experimental approaches to study AS:
RT-PCR with isoform-specific primers across bovine tissues
RNA-Seq analysis with focus on splice junction reads
Minigene assays to test splicing regulation mechanisms
Expression of individual isoforms to assess functional differences
Given the importance of AS in immune regulation, and considering that 64% of alternative splicing events affected by RBFOX2 deletion are directly bound by RBFOX2 , investigation of similar mechanisms for RELL2 could reveal important regulatory pathways in bovine immune cells.